Affiliation:
1. Department of Pharmacognosy Amrita School of Pharmacy Amrita Vishwa Vidyapeetham AIMS Health Science Campus Ponekkara, P.O. Kochi Kerala 682041 India
2. Department of Pharmacology Amrita School of Pharmacy Amrita Vishwa Vidyapeetham AIMS Health Science Campus Ponekkara, P.O. Kochi Kerala 682041 India
3. Department of Pharmaceutics Amrita School of Pharmacy Amrita Vishwa Vidyapeetham AIMS Health Science Campus Ponekkara, P.O. Kochi Kerala 682041 India
4. Department of Pharmacology Yong Loo Lin School of Medicine National University of Singapore Singapore 117600 Singapore
Abstract
ScopeHepatocellular carcinoma (HCC) results from various etiologies, such as Hepatitis B and C, Alcoholic and Non‐alcoholic fatty liver disorders, fibrosis, and cirrhosis. About 80 to 90% of HCC cases possess cirrhosis, which is brought on by persistent liver inflammation. TGF‐β is a multifunctional polypeptide molecule that acts as a pro‐fibrogenic marker, inflammatory cytokine, immunosuppressive agent, and pro‐carcinogenic growth factor during the progression of HCC. The preclinical and clinical evidence illustrates that TGF‐β can induce epithelial‐to‐mesenchymal transition, promoting progression and hepatocyte immune evasion. Therefore, targeting the TGF‐β pathway can be a promising therapeutic option against HCC.Methods and ResultsWe carry out a systemic analysis of eight potentially selected culinary Indian spices: Turmeric, Black pepper, Ginger, Garlic, Fenugreek, Red pepper, Clove, Cinnamon, and their bioactives in regulation of the TGF‐β pathway against liver cancer.ConclusionTurmeric and its active constituent, curcumin, possess the highest therapeutic potential in treating inflammation‐induced HCC and they also have the maximum number of ongoing in‐vivo and in‐vitro studies.